The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pharmacy and Therapeutics Committee

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pharmacy and Therapeutics Committee


High impact information on Pharmacy and Therapeutics Committee


Associations of Pharmacy and Therapeutics Committee with chemical compounds


Gene context of Pharmacy and Therapeutics Committee


  1. Current perspectives on anabolic-androgenic steroid abuse. Lukas, S.E. Trends Pharmacol. Sci. (1993) [Pubmed]
  2. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. Wilson, T.A., Rose, S.R., Cohen, P., Rogol, A.D., Backeljauw, P., Brown, R., Hardin, D.S., Kemp, S.F., Lawson, M., Radovick, S., Rosenthal, S.M., Silverman, L., Speiser, P. J. Pediatr. (2003) [Pubmed]
  3. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Sweis, D., Wong, I.C. Drug safety : an international journal of medical toxicology and drug experience. (2000) [Pubmed]
  4. Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). Juul, A., Bernasconi, S., Carel, J.C., Clayton, P.E., Kiess, W., DeMuinck-Keizer Schrama, S. Horm. Res. (2003) [Pubmed]
  5. Formulary management of colony-stimulating factors. Whalen, C.R., Watson, T.L., Baize, T., Ball, A. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. (2002) [Pubmed]
  6. Therapeutic-interchange program for oral histamine H2-receptor antagonists. Chase, S.L., Peterson, A.M., Wordell, C.J. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. (1998) [Pubmed]
  7. Antimicrobial formulary management: a case study in a teaching hospital. Wright, D.B. Pharmacotherapy (1991) [Pubmed]
  8. A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron. Dranitsaris, G., Warr, D., Puodziunas, A. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. (1995) [Pubmed]
  9. Pharmacy and therapeutics committee review of the parenteral cephalosporins. Phelps, M.R., Godwin, H.N. American journal of hospital pharmacy. (1978) [Pubmed]
  10. Effect of aminoglycoside-use restrictions on drug cost. DeTorres, O.H., White, R.E. American journal of hospital pharmacy. (1984) [Pubmed]
  11. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. Hayman, J.N., Sbravati, E.C. American journal of hospital pharmacy. (1985) [Pubmed]
  12. The Pharmacy and Therapeutics Committee Part 1: overview. Bender, F.H. Hospital formulary. (1983) [Pubmed]
  13. CQI case study: reducing medication errors. Carey, R.G., Teeters, J.L. The Joint Commission journal on quality improvement. (1995) [Pubmed]
WikiGenes - Universities